Michael Smith
Pediatric Infectious Diseases · Louisville, KYNPI 1336340454
Payments from drug & device makers
Across 145 payments — averaging $7672.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$826K
- Merck$171K
- Tetraphase Pharmaceuticals, Inc.$105K
- Sanofi Pasteur Inc.$8K
- Modernatx, Inc.$3K
Across 3 payments — averaging $1586.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$5K
What the payments were for
- Consulting fees$3,60068%
- Travel & lodging$1,39226%
- Food & beverage$3306%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 94 | $825,705 |
| Merck | 20 | $170,934 |
| Tetraphase Pharmaceuticals, Inc. | 27 | $104,857 |
| Sanofi Pasteur Inc. | 2 | $8,000 |
| Modernatx, Inc. | 2 | $2,993 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PREVYMIS$1,542
How this compares
Too few pediatric infectious diseases providers in Kentuckyto place this figure against a meaningful peer group, so we don't.
Other pediatric infectious diseases in Louisville
- Gary MarshallLouisville$1.9M
- Victoria StatlerLouisville$403K
- Kristina BryantLouisville$200K
- Daniel BlattLouisville$172K
- Shanna BartonLouisville$14K
- Navjyot VidwanLouisville$370
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.